[ CARB-X - Vaccines and Biotherapeutics for antibiotic resistant bacteria | Research funding ]
Event details
| Date | 15.06.2019 |
| Category | Call for proposal |
Aim: CARB-X welcomes applications from around the world for funding and support for the early development of antibiotics, diagnostics, vaccines and other products to combat the most serious drug-resistant bacteria. The goal is to support them through the early stages of product development and Phase 1 so they can attract private or public investment for further clinical stage development.
Round 2 for this program focuses on Vaccines and Biotherapeutics. In particular:
For vaccines and other therapeutics, CARB-X funds projects from Hit-to-Lead into Phase 1.
Funding: Project dependent.
Duration: Project dependent.
Eligibility: CARB-X welcomes applications from around the world. Applicants must have a legal entity. Product developers (PDs) must have appropriate operations or capabilities in place to support product development, particularly through the development stages in scope for CARB-X.
How to Apply: There is a three-step application process. First, an Expression of Interest (EOI) must be submitted summarizing the product proposed as a candidate for support. EOIs are submitted on the application portal. Selected applicants then move to the second step, in which selected companies submit a confidential Short Form. Finally, in a third step selected applicants submit a Long Form and detailed budget.
EOI Deadline: 15 June 2019
Further information
Round 2 for this program focuses on Vaccines and Biotherapeutics. In particular:
- Vaccines
- Therapeutic and preventative antibodies and fragments
- Other large molecule biotherapeutics (not direct- or indirect-acting peptides)
For vaccines and other therapeutics, CARB-X funds projects from Hit-to-Lead into Phase 1.
Funding: Project dependent.
Duration: Project dependent.
Eligibility: CARB-X welcomes applications from around the world. Applicants must have a legal entity. Product developers (PDs) must have appropriate operations or capabilities in place to support product development, particularly through the development stages in scope for CARB-X.
How to Apply: There is a three-step application process. First, an Expression of Interest (EOI) must be submitted summarizing the product proposed as a candidate for support. EOIs are submitted on the application portal. Selected applicants then move to the second step, in which selected companies submit a confidential Short Form. Finally, in a third step selected applicants submit a Long Form and detailed budget.
EOI Deadline: 15 June 2019
Further information
- More details on the call can be found on the application website.
- A pre-recorded webinar explaining the 2019 calls can be found here.
- For any other questions, contact the Research Office.
Practical information
- General public
- Free